Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.

Ítems similars

• Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
  per: Hast, M, et al.
  Publicat: (2009)
• Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.
  per: Fletcher, S, et al.
  Publicat: (2008)
• Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
  per: Gajewski Thomas F, et al.
  Publicat: (2012-12-01)
• Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
  per: Van Voorhis, W, et al.
  Publicat: (2007)
• Farnesyltransferase inhibitors.
  per: Hahn, S, et al.
  Publicat: (2001)